A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)

NCT01003431 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Rotavirus Gastroenteritis
Diphtheria
Tetanus
Pertussis

Interventions

BIOLOGICAL: Rotavirus Vaccine, Live, Oral, Pentavalent
BIOLOGICAL: Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP)
BIOLOGICAL: Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP)

Sponsor

Merck Sharp & Dohme LLC